Dexanabinol: Approval to begin immediate Phase II testing

Pharmos Corp. (PARS), Alachua, Fla. Product: Dexanabinol (HU-211) synthetic neuroprotective agent Indication: Moderate to severe head injury Status: PARS received Israeli approval to begin immediate P...